Silicon Valley - Triple Ring Technologies, Newark (CA)
January 16th 2025 (PST)
09:00 AM - 09:00 PM
Sharing insights on the latest trends in AI Biohealthcare and Drug Discovery while providing dedicated networking opportunities and 1:1 partnering sessions.
The AI Biohealthcare & Drug Discovery Summit aims to accelerate innovation and collaboration in the biohealthcare sector by leveraging the latest advancements in artificial intelligence. Researchers, industry experts, and corporate leaders will come together to discuss cutting-edge trends, share insights, and explore opportunities for global partnerships in AI-driven healthcare solutions. This summit provides a platform to exchange ideas on AI powered drug discovery, technology based startups, and research cooperation. Attendees will explore practical approaches to strengthen collaboration and advance competitiveness in the global biohealthcare market.
Through this event, we aim to inspire innovation, foster strategic alliances, and drive the growth of technology driven initiatives in the biohealthcare and pharmaceutical industries.
To register,
please click the button
and fill out the form.
Password: 080324
Stephen Kosslyn
President
Active Learning Sciences
Byunggeon Rhee
Chairman & CEO
GI Innovation
Mark de Souza
President & CEO
SonALASense
Jamie Choi
CEO & Founding Partner
Numeri
Priyank Jain
IBM
Jaecheol Lee
Associate Professor
Sungkyunkwan University
Mohamed Elhoseiny
Professor
KAUST
Okyaz Eminaga
CEO, AI Vobis
Stanford Univeristy
Rachna Dayal
CEO
Sugati Ventures
James Park
President & CEO
Lotte Biologics
Peter Beack
CEO
BSR Korea
Christopher Korban
CEO
Revilco
Jeewon Kim
Program mannager
Stanford / Spark
Goonho Park
CEO
PathoBrainSeq
Max Salamonowicz
CTO
Migam.ai
Jeehee Lee
Postdoctoral Fellow
Stanford University
Sabeer Bhatia
Founder, Hotmail CEO
ShowReel
John A. Bogdan
President
Valaria Technical Consultants
Sunhee Kim
Vice President
Lions Club International-SF
Arnold Lee
CMO
Sugati Ventures
Henry Bang
Vice President
KACCUSA
Soh Kim
Director
Stanford / SCIDR
Ryan McGuinness
Global Head
TripleRing Technologies
Kyuho Han
CEO
Medic
Kyenghee Kwon
Professor
Dongguk Univ
Pawel Kusmierowski
CEO
Deloitte Digital
Tanya O.
President
JHTCsv
Jaeho Kim
President
KU Alumni Association in SV
Jungyoon Lee
Scientist
SK Biopharm
Peter Bae
Diretor
KIC in Sillcon Valley
James Jahng
Instructor
Stanford University
Christian Gruber
Founder / CEO
Innophore
Margarette Ell-Kesselman
Limited Partner Investor
J-Ventures Fund
Yeohoon Park
Partner (Attorney)
Pillsbury Winthrop Shaw Pittman LLP
Soojung Han
Stanford GSB
Kyunghee Lim
Specialist
Consulate General of the
Republic of Korea in SF
JaeB Kim
Director
Gilead Sciences
Kwontae You
Group Leader
Xaira Therapeutics
Sue Kim
VP of Corporate Marketing
ANAFLASH
Bumsoo Kim
Managing Partner
Translink Investment
Renee Yao
Ecosystem BD
NVIDIA
Jooyeon Kim
Director
KDDF
Uri Lee
Community Lead
Likelion Us
Kwangrog Kim
Managing Partner
Sazze Partners
Jihoon Jeong
General Partner
Asia2G Capital
Minnat Allah
Mohammed
University of Cambridge
Bokhwan Chun
CBO
KDDF
Pawel Morkisz
DL Algorithms Manager
NVIDIA
Bumsoo Kim
Managing Partner
Translink Investment
Taejin Yoon
Executive Director
Yuhan Coop
SJ Lee
CEO
Orum Therapeutics
Salvatore Giovanni
Viscomi, CEO
Carna Health
Harald Nuhn
LEAD
Stanford GSB
Phillip Mohabir
CEO
Vivo Surgery
Gary Goldman
CEO
Global Health Impact Fund
Keshia Theobald-van
Gent
VP, BDev Ventures
PST 2025.01.16 09:00 (AM)
KST 2025.01.17 02:00 (AM)